Which finding would least support a diagnosis of neuroblastoma?

Which finding would least support a diagnosis of neuroblastoma?

• A. Increased blood dopamine levels
• B. Increased blood epinephrine levels
• C. Increased urinary homovanillic acid
• D. Decreased urinary vanillylmandelic acid

Answer: (D)

Catecholamine metabolism drives the biochemical signature of neuroblastoma. Tumor cells often produce catecholamines, and their breakdown products accumulate in the body, with urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) being the classic markers. Because VMA is a major end product of catecholamine metabolism, its urinary level is typically elevated in patients with a catecholamine-secreting tumor like neuroblastoma. A finding of decreased urinary VMA would contradict this usual pattern and thus provides the least support for the diagnosis. By contrast, elevated dopamine levels in blood, and increased urinary HVA, align with the expected catecholamine activity in neuroblastoma; elevations in epinephrine can occur but are less consistent, so they remain more compatible with the diagnosis than a drop in VMA.

Catecholamine metabolism drives the biochemical signature of neuroblastoma. Tumor cells often produce catecholamines, and their breakdown products accumulate in the body, with urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) being the classic markers. Because VMA is a major end product of catecholamine metabolism, its urinary level is typically elevated in patients with a catecholamine-secreting tumor like neuroblastoma. A finding of decreased urinary VMA would contradict this usual pattern and thus provides the least support for the diagnosis. By contrast, elevated dopamine levels in blood, and increased urinary HVA, align with the expected catecholamine activity in neuroblastoma; elevations in epinephrine can occur but are less consistent, so they remain more compatible with the diagnosis than a drop in VMA.